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A region of 12 kb flanking the structural gene of the cyclic antibacterial peptide circularin A of Clostridium
beijerinckii ATCC 25752 was sequenced, and the putative proteins involved in the production and secretion of
circularin A were identified. The genes are tightly organized in overlapping open reading frames. Heterologous
expression of circularin A in Enterococcus faecalis was achieved, and five genes were identified as minimally
required for bacteriocin production and secretion. Two of the putative proteins, CirB and CirC, are predicted
to contain membrane-spanning domains, while CirD contains a highly conserved ATP-binding domain. To-
gether with CirB and CirC, this ATP-binding protein is involved in the production of circularin A. The fifth
gene, cirE, confers immunity towards circularin A when expressed in either Lactococcus lactis or E. faecalis and
is needed in order to allow the bacteria to produce bacteriocin. Additional resistance against circularin A is
conferred by the activity of the putative transporter consisting of CirB and CirD.
Antimicrobial peptides or bacteriocins are produced by var-
ious gram-positive and gram-negative bacteria. Although many
bacteriocins inhibit the growth of strains closely related to the
bacteriocin producer, an ever-increasing number of bacterio-
cins have a broader activity range. Only a few antimicrobial
peptides of clostridial origin have been characterized at the
molecular level, despite their extensive use as a means of
identifying and typing clostridia (24, 32). The three bacterio-
cins that have been partially characterized are BCN5, boticin
B, and circularin A (9, 12, 25), produced by Clostridium per-
fringens, Clostridium botulinum, and Clostridium beijerinckii,
respectively.
Circularin A, a circular bacteriocin produced by C. beijer-
inckii ATCC 25752, is active against a broad range of gram-
positive bacteria (25). The circularization of the peptide in-
volves a head-to-tail peptide bond formation between the
fourth and last amino acid of the precursor peptide (25). Cir-
cularin A shares limited sequence homology with enterocin
AS-48 (also known as Bac21), a cyclic bacteriocin from Entero-
coccus faecalis (34, 56), but its precursor lacks the long leader
present in the enterocin AS-48 precursor. The circularin A
gene cluster is chromosomally located, while the enterocin
AS-48 operon is located on a plasmid.
Both circularin A and enterocin AS-48 belong to the re-
cently defined class V bacteriocins of ribosomally synthesized,
nonmodified, head-to-tail-ligated cyclic antibacterial peptides
(25). Other class V bacteriocins are microcin J25 and gasseri-
cin A (4, 22). Microcin J25, peptide of 21 amino acid residues
produced by Escherichia coli, is the only circular peptide
known so far that is produced by a gram-negative bacterium
(4). The genes involved in the production of microcin J25 are
located in an operon immediately downstream of the structural
gene (51). Gassericin A is produced by Lactobacillus gasseri as
a 91-amino-acid precursor peptide that is circularized after
removal of a leader peptide of 33 amino acids (22, 23). The
coding regions of enterocin AS-48 of two strains have been
sequenced and determined to be almost identical (35, 56).
Enterocin AS-48 is a tightly packed peptide containing five
-helices and is structurally related to NK-lysin, a cytotoxic
peptide from human natural killer or T cells (16).
Most bacteriocins require processing of a precursor peptide
in order to become (fully) active. For many bacteriocins, the
genes encoding processing, secretion, and immunity functions
flank the structural gene. Processing can involve modification
of amino acids, as is the case in lantibiotics, leader peptide
removal, or, in the case of circular peptides, circularization.
The mechanisms underlying these modifications are poorly
understood, although the proteins involved are generally
known. The secretion of most bacteriocins occurs via dedicated
ABC transporters (26), while some can be secreted via the
general secretion pathway (5, 21, 33).
Immunity systems for bacteriocins are poorly characterized,
but it has been demonstrated that specialized immunity pro-
teins confer immunity to bacteriocin action on cells by blocking
access to a putative receptor, as is the case for the lactococcin
A immunity protein LciA (58). In some cases ABC transport-
ers have been shown to be involved, e.g., the NisFEG system in
nisin resistance and McbFE in microcin B17 resistance (13,
43). Little homology exists among bacteriocin immunity pro-
teins, even those that are involved in immunity against bacte-
riocins of the same class.
In this study we identified the genes required for functional
heterologous expression of circularin A and showed that two
independent mechanisms confer reduced circularin A sensitiv-
ity, one of which is based on the expression of cirE and the
other on the combined expression of cirB and cirD. As such,
this study will further the field of clostridial bacteriocins and
that of class V (circular) bacteriocins in particular.
* Corresponding author. Mailing address: Department of Molecular
Genetics, University of Groningen, Kerklaan 30, 9751 NN Haren, The




Bacterial strains, media, and reagents. The strains and plasmids used in this
study are listed in Table 1. Clostridium beijerinckii ATCC 25752 was grown
anaerobically at 30°C in AC broth (Difco, Detroit, Mich.). Anaerobicity was
obtained by chemical absorption of the oxygen in closed bottles as previously
described (25). Lactobacillus sake´ ATCC 15521 was grown in De Man Rogosa
and Sharpe (MRS; Merck, Darmstadt, Germany) broth at 30°C. Twofold-diluted
M17 broth (Difco) with a final concentration of 1.9% -glycerophosphate
(Merck) and 0.5% glucose (G[1/2]M17) was used for growth of Lactococcus lactis
NZ9000 and Enterococcus faecalis JH2-2 at 30°C and 37°C, respectively. Esche-
richia coli DH5 was grown for 16 h in tryptone-yeast (TY) broth at 37°C with
vigorous agitation (250 rpm). For growth on plates, medium containing 1.5%
agar was used. Ampicillin (Sigma, Zwijndrecht, The Netherlands) and chloram-
phenicol (Sigma) were used at 100 and 10 g/ml, respectively, for E. coli.
Chloramphenicol and erythromycin (Sigma) were used at 5 g/ml each for L.
lactis NZ9000 and at 20 and 2 g/ml, respectively, for E. faecalis JH2-2. When
used together, chloramphenicol and erythromycin were employed at 2.5 g/ml
each for Lactobacillus sake´ ATCC 15521 or at 10 g/ml (chloramphenicol) and
2 g/ml (erythromycin) for E. faecalis JH2-2.
Nucleotide sequencing. Inverse PCR techniques with the nucleotide sequence
of cirA (25) were employed to obtain the region surrounding the cirA gene. PCR
products were sequenced either directly or after subcloning of restriction enzyme
digestion fragments in pUC19. PCR products were purified with the High Pure
PCR product purification kit of Roche (Roche Diagnostics GmbH, Mannheim,
Germany). Sequencing was performed with indodicarbocyanine-labeled univer-
sal, reverse, or T7 primers (Amersham Pharmacia Biotech, Roosendaal, The
Netherlands) and the ALFII system (Amersham Pharmacia Biotech) according
to the protocols of the supplier with the following modifications: the power was
set at 15 and 18 W for the long-read and high-resolution gels, respectively.
Bacteriocin assays. Colony overlayer assays were performed as described
previously (25). Bacteriocin activity in C. beijerinckii ATCC 25752 supernatant
was quantified in triplicate by a critical dilution assay as described by Geis et al.
(14), with the modification that assays were performed in microtiter plates. To 50
l of serially diluted, bacteriocin-containing samples, 150 l of medium contain-
ing the indicator strain Lactobacillus sake´ ATCC 15521(pMG36e; pMG36c),
diluted 100-fold from a stationary-phase overnight culture, was added unless
mentioned otherwise. Resistance to bacteriocin was determined by plating
strains on plates containing 4 or 10% (vol/vol) filter-sterilized C. beijerinckii
ATCC 25752 supernatant containing circularin A. Alternatively, a critical-dilu-
tion assay was performed with the strain of interest as an indicator strain. In
these critical-dilution assays, 100 l of bacteriocin-containing sample was mixed
with 100 l of freshly diluted (1,000-fold) indicator strains.
Cloning methods and materials. Molecular cloning techniques were per-
formed essentially as described by Sambrook et al. (45). Restriction enzymes, T4
DNA ligase, and Expand DNA polymerase were obtained from Roche (Roche
Diagnostics GmbH) and used as specified by the supplier. L. lactis NZ9000 was
transformed as described by Shepard and Gilmore (19) with 1% glycine (Merck).
E. faecalis JH2-2 was transformed as described previously (47; http:
//w3.ouhsc.edu/enterococcus) with 8% glycine. After transformation, both strains
were plated on G[1/2]M17 medium containing 0.5 M sucrose and the appropriate
antibiotics. Plasmids from L. lactis NZ9000, Escherichia coli DH5, and E.
faecalis JH2-2 were isolated according to Birnboim (3), with the following mod-
ifications for E. faecalis: mutanolysin (1 U/ml; Sigma) was added to the suspen-
sion buffer to facilitate lysis, and plasmids isolated from 50 ml of culture were,
after RNase (0.5 mg/ml; Sigma) treatment, further purified with the High Pure
PCR product purification kit (Roche Diagnostics GmbH).
Cloning of the circularin A determinant. The region encompassing cirA to cirE
was amplified with primers located just upstream of cirA (B51426, 5-ACGCG
TCGACTCATGAGTTTTTCAAAAGGAGGTGATTAATT ATGTTTTTATT
GCAGG-3) and downstream of cirE (B51427, 5-CGCGGATCCGTCGACCT
CTCCCACTTTAACATTAGTTATTGCTC-3). SalI-RcaI and BamHI-SalI
sites, respectively, in the two primers are underlined. All enzymes (Roche) were
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Descriptiona Reference or sourceb
C. beijerinckii ATCC 25752 Circularin A producer NIZO
E. faecalis JH2-2 Plasmid-free derivative of E. faecalis JH-2 20
L. lactis NZ9000 Plasmid-free derivative of L. lactis MG1363, pepN::nisRK 30
Lactobacillus sake ATCC 15521 Bacteriocin indicator lab collection
E. coli Top10 F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1
deoR araD139 (ara-leu)7697 galU galK rpsL (Strr) endA1
nupG
Invitrogen




pMG36c Cmr, pWV01-based cloning vector carrying the strong
lactococcal promoter P32
Laboratory collection
pMG36e Emr, gene expression vector carrying P32 57
pCR21 Ampr Kmr Invitrogen
pCRAE Ampr Kmr This study
pIL253 Emr, theta replicating cloning vector 49
pIL-E Emr, pIL253 derivative with cirE under control of P32 This study
pIL-P32 Emr, pIL253 derivative with P32 promoter This study
pMGAE1 Cmr, pMG36c derivative with cirABCDE under control of P32 This study
pCir Cmr, derivative of pMGAE1 overexpressing circularin A This study
pCirA Cmr, pCir cirA This study
pCirB Cmr, pCir cirB This study
pCirC Cmr, pCir cirC This study
pCirD Cmr, pCir cirD This study
pCirE Cmr, pCir cirE This study
pCirAE Cmr, pCir cirA cirE This study
pCirBE Cmr, pCir cirB cirE This study
pCirCE Cmr, pCir cirC cirE This study
pCirDE Cmr, pCir cirD cirE This study
pCirACE Cmr, pCir cirA cirC cirE This study
pCirABCE Cmr, pCir cirA cirB cirC cirE This study
pCirACDE Cmr, pCir cirA cirC cirD cirE This study
pMG-E Emr, pMG36e derivative with cirE under control of P32 This study
a Ampr, ampicillin resistance; Cmr, chloramphenicol resistance; Emr, erythromycin resistance; Kmr, kanamycin resistance.
b NIZO, NIZO Food Research Ede, The Netherlands; Invitrogen, Breda, The Netherlands.
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used according to the manufacturer’s instruction. The PCR product was cloned
with the Zero-Blunt Topo PCR cloning kit (Invitrogen, Breda, The Nether-
lands), creating pCRAE. The plasmid pCRAE was digested with SpeI and XhoI.
The fragment carrying cirA was ligated into pMG36c digested with XbaI and SalI,
and the ligation mixture was used to transform E. coli DH5. Transformants
were identified by growth on TY agar with chloramphenicol. The correct plas-
mid, pMGAE1, was isolated as described above and introduced into E. faecalis
JH2-2. Three consecutive selection steps of clean streaking and testing for a
strain with a high and stable bacteriocin expression phenotype with the colony
overlay assay yielded E. faecalis JH2-2 carrying a pMGAE1 derivative labeled
pCir.
In-frame deletions of cirA through cirD were made by amplifying pCir by PCR
with appropriate outward-facing primers, creating a PCR product of the entire
plasmid but lacking the gene of interest. The primers used were 5-AGTATGG
CAAGAGCTATAGC-3 and 5-CACGCCTAGTGCTCCTGC-3 for cirA, 5-
TAATTATGCCTGTATCATACC-3 and 5-CCAAGAGTTATAGTTTGAGT
CG-3 for cirB, 5-GTGCACATAGGTAGGATTTTAAG-3 and 5-GAAAC
ATTCC AACAATAATACC-3 for cirC, and 5-GAACTTAATCTAGTTAA
CGGAAG-3 and 5-AGTTATCTCTAGCATAGGCTTC-3 for cirD.
Each PCR product was kinase treated with T4 polynucleotide kinase (Amer-
sham Pharmacia Biotech) in T4 ligase buffer (Roche Diagnostics GmbH) and
subsequently self-ligated with T4 ligase, creating the plasmids pCirA, pCirB,
pCirC, and pCirD. Derivatives of pCir with a deletion of cirE and a deletion
of one of the other genes cirABCD, pCirAE, pCirBE, pCirCE, or pCirDE,
were made by the same method with the primers 5-CATATATTCTACTACC
TTTC-3 and 5-GTAATTAAAGGCTCTAATAAG-3 for cirE and the plas-
mids carrying the respective single deletions as templates in the PCR. A plasmid
with a triple deletion, pCirACE, was constructed likewise by deleting cirC with
pCirAE as a template and the primers used for the single deletion of cirC.
Based on pCirACE, pCirABCE and pCirACDE were made with the prim-
ers employed for the single knockouts of cirB and cirD, respectively. All plasmids
were isolated with E. faecalis JH2-2 as the cloning host.
The cirE gene was cloned behind the lactococcal chromosomal P32 promoter
by digesting the PCR product obtained with primers B51426 and B51427 and
HpaI and SalI and ligating the cirE-carrying fragment into SmaI- and SalI-
digested pMG36e, leading to pMG-E. Colonies obtained after transformation of
L. lactis NZ9000 were replica streaked onto G[1/2]M17 plates with 4% (vol/vol)
C. beijerinckii ATCC 252752 supernatant to screen for circularin A immunity.
The plasmid was isolated and used to transform E. faecalis JH2-2. In order to
make pCirE, a fragment with the immunity gene cirE behind the P32 promoter
was first cloned in pIL253 to avoid possible lethal effects of bacteriocin expres-
sion without immunity. This was done by digesting pMG-E with EcoRI and SalI
and ligating the cirE-carrying fragment into pIL253 digested with the same
enzymes. The resulting plasmid (pIL-E) was introduced into E. faecalis JH2-2.
pCirE was subsequently made with pCir as a template and the appropriate
primers. E. faecalis JH2-2(pIL-E) was used as the host for construction of
pCirE.
Computational analyses. Open reading frames were identified with the Glim-
mer 2.0 program (6). Predictions by the Glimmer 2.0 program were checked
manually for validity. Homology comparisons were performed with the basic
logical alignment tool (Blast) as described by Altschul et al. (1). Blast searches
were performed against the NCBI nonredundant protein database and the NCBI
microbial genomes database (http://www.ncbi.nlm.nih.gov/BLAST/). Homolo-
gies with conserved domains from the Pfam database (http://www.sanger.ac.uk
/Software/Pfam/) (2) were also identified with Blast searches. Putative signal
peptides were identified with signalP (http://www.cbs.dtu.dk/services/SignalP/)
(38). Putative transmembrane helices were identified with the TMHMM2.0 pro-
gram (http://www.cbs.dtu.dk/services/TMHMM-2.0/) (28). Dyad symmetries, iso-
electric points, and molecular weights were determined with the program Clone-
manager 4 (SEcentral; Scientific & Educational Software). Sequence alignments
were performed with the ClustalW program available at http://www2.ebi.ac.uk
/clustalw/ (54).
Nucleotide sequence accession number. The cirA sequence is available under
GenBank accession number AJ566621.
RESULTS
Sequence analysis of the region encompassing the struc-
tural gene of circularin A. The structural gene of the circular
bacteriocin circularin A of Clostridium beijerinckii ATCC
25752 (cirA) has previously been cloned and sequenced (25). A
region of 11 kb surrounding cirA was sequenced and shown to
contain 12 open reading frames (ORFs), including cirA (Fig. 1
and 2). Six putative promoters were identified, one upstream of
each cfgR (cirA-flanking gene response regulator), cfg01 (cirA-
flanking gene 01), cfg02, cirA, cirB, and cirG. The cirBCDE and
cirGHI genes are putatively transcribed as polycistronic mes-
sengers, since no clear transcription initiation signals were
detected other than the ones upstream of cirB and cirG, re-
spectively. Translation of cirC and cirD can putatively start
from alternative start codons within the same reading frame
(Fig. 2). Overlap between the end of one gene (cfgR, cirC, cirD,
cirH, and cirI) and the predicted start of the downstream gene,
which is suggestive of regulation of expression by translational
coupling, is a common feature in the entire region (Fig. 2). For
cirH, translational coupling to cirG would be the only means of
expression, as it lacks an obvious ribosome-binding site (Fig.
2).
Derived protein sequences and homologies are presented in
Table 2. The gene products CirB through CirI all show some
degree of homology to proteins involved in the production of
enterocin AS-48, a bacteriocin produced by Enterococcus fae-
calis S-48 (34). Homologues of the putative proteins AS-48C1
and Bac21F are not encoded by the cir operon. CirD and CirH,
like AS-48D and BacH, both contain an ATP-binding domain
(Fig. 3). CirG belongs to the HlyD family of accessory proteins
of ABC transporters, which includes proteins like EmrA, an
accessory protein in the EmrAB multidrug transporter (31),
and LcnD, an auxiliary protein involved in the secretion of the
bacteriocin lactococcin A (11).
Based on the occurrence of the G-X9-F-X10-G motif, CirI
can be classified in the ortholog group 3-1 of ABC transport-
ers, as defined by Tomii and Kanehisa (55). Like the already
characterized members of this group (FtsX [7] and LolC and
LolE [37]), CirI contains four putative transmembrane do-
mains, typical of group 3-1 ABC transporters (Fig. 4), and a
Duf214 domain of predicted permeases, as defined in the Pfam
database. CfgR and CfgK are homologous to response regu-
lators and histidine kinases, respectively, of two-component
regulatory systems. Cfg01 is homologous (24% identity) to the
accessory gene regulator (AgrB) of Staphylococcus aureus,
which is thought to be involved in processing and secretion of
a signaling peptide (AgrD), regulating a large set of virulence
factors (61). Cfg02 is homologous to two putative proteins with
unknown function from C. acetobutylicum and C. perfringens
(34% identity with each of these proteins) (39, 48).
Circularin A production in a heterologous host. The region
encompassing cirABCDE was cloned in the broad-host-range
vector pMG36c downstream of the constitutive lactococcal
promoter P32, creating pMGAE1. E. faecalis JH2-2(pMGAE1)
produced a small amount of bacteriocin and was resistant to
circularin A (Fig. 5), but bacteriocin production was not stable.
Three consecutive cycles of selection for bacteriocin produc-
tion by overlay assay and subsequent clean-streaking of pro-
ducing colonies yielded a strain that stably expressed a high
level of circularin A (Fig. 5). The plasmid in this strain, des-
ignated pCir, was identical to pMGAE1 by restriction enzyme
analysis. The high bacteriocin expression level was maintained
upon plasmid isolation and reintroduction into E. faecalis
JH2-2. The copy numbers of pCir and pMGAE1 were clearly
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reduced compared to the copy number of the empty vector
pMG36c (data not shown).
Functional analysis of the circularin A gene cluster. In order
to determine which genes are involved in the production of
circularin A, pCir was used as a template to create in-frame
single deletions of cirA, cirB, cirC, or cirD. E. faecalis JH2-2
strains harboring the various plasmids all lost the CirA phe-
notype, as revealed by colony overlayer assays (Fig. 1). All
strains remained resistant to circularin A, as they grew on
plates containing filter-sterilized culture supernatant (10%,
vol/vol) of C. beijerinckii ATCC 25752, while E. faecalis JH2-
2(pMG36c) did not (Fig. 1). These results indicate that each of
the four gene products is required for the production of active
circularin A.
Removal of cirE from the cirABCDE cluster in pCir could
not be achieved in several attempts with different cloning hosts
[E. faecalis JH2-2 and E. faecalis JH2-2(pMGE)], while simul-
taneous deletion of cirA and cirE (pCirAE) was possible. This
observation suggested that cirE is involved in bacteriocin im-
munity, an assumption that will be discussed further below. E.
faecalis JH2-2(pCirAE) showed reduced sensitivity to circu-
larin A present in filter-sterilized culture supernatant of C.
beijerinckii ATCC 25752 but was clearly more resistant to cir-
cularin A than E. faecalis(pMG36c).
To determine which gene(s) is involved in this partial resis-
tance towards circularin A, single deletions of cirB, cirC, and
cirD were combined with a deletion in cirE. A mutation in
either cirB or cirD in combination with deletion of cirE led to
the loss of the circularin A-resistant phenotype, whereas cells
carrying a pCir derivative with a deletion in cirA or cirC in
combination with cirE remained partially resistant to circularin
A (Fig. 1). These results indicate that both CirB and CirD are
required for partial resistance in the absence of CirE. To con-
firm this hypothesis, three additional deletion constructs were
made. E. faecalis JH2-2(pCirACE), specifying only CirB and
CirD, still showed partial resistance to CirA. E. faecalis JH2-2
expressing only CirB (pCirACDE) or CirD (pCirABCE)
was bacteriocin sensitive, confirming that both CirB and CirD
FIG. 1. (A) Physical map of the region surrounding the circularin A structural gene cirA of C. beijerinckii ATCC 25752. Solid arrows indicate
genes; bent arrows show putative promoters; lollipops represent predicted regions of dyad symmetry (G0  	10 kcal/mol); dotted arrows show
possible polycistronic messengers. Map units are base pairs. (B) Schematic representation of the cir DNA fragments in the indicated plasmids and
locations of the deletions (indicated by the thin lines). Open arrowheads indicate a deletion in cirE. Promoters are shown by bent arrows. CirA,
circularin A production; CirR, circularin A resistance, denoted as , full protection against CirA [
24-fold increase relative to E. faecalis
JH2-2(pMG36c)]; , partial protection [2- to 16-fold increase relative to E. faecalis JH2-2(pMG36c)]; 	, sensitive.
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are needed for the partial resistance phenotype in the absence
of CirE.
Heterologous expression of circularin A in L. lactis NZ9000
was attempted, but pCir and any other vector containing cirB
did not give transformants, while all control plasmids did. Ap-
parently, an intact cirB gene is lethal to this host. Plasmids with
a deletion in cirB could be stably maintained in L. lactis. L.
lactis(pCirB) did not produce active CirA and was 2.5-fold
more resistant to the bacteriocin than L. lactis(pNG8048e), a
strain carrying an empty cloning vector.
cirE gene confers circularin A immunity. To prove that cirE
can confer bacteriocin resistance independent of the combina-
tion cirB and cirD, the gene was cloned downstream of the
lactococcal promoter P32 in pMG36e (pMG-E). Unlike L.
lactis(pMG36e), L. lactis NZ9000(pMG-E) was able to grow in
a medium with culture supernatant (up to 50%, vol/vol) of C.
beijerinckii ATCC 25752 (CirA), as determined by serial di-
lution assay. L. lactis NZ9000(pMG-E) also formed normal
colonies on plates containing filter-sterilized C. beijerinckii
ATCC 25752 culture supernatant (4%, vol/vol), whereas the
FIG. 2. (A) Nucleotide sequences of promoter and translation initiation regions in the cir gene cluster. Putative 	35, 	10, and ribosome-
binding site (RBS) sequences are underlined. Deduced amino acid sequences are indicated below the nucleotide sequences, and gene names are
given below the amino acid sequences. Putative start codons are indicated in boldface and are numbered when more than one possibility exists.
Termination codons are underlined and in italic.
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control strain did not grow at all. These results indicate that
cirE alone gives rise to circularin A resistance. E. faecalis JH2-
2(pMG-E) was also immune to the bacteriocin present in C.
beijerinckii ATCC 25752 supernatant, as determined in a plate
assay.
As mentioned above, initial attempts to remove cirE from
cirABCDE with either E. faecalis JH2-2 or E. faecalis JH2-
2(pMG-E) as the cloning host failed. This problem was cir-
cumvented by cloning cirE downstream of the P32 promoter in
pIL253. The resulting strain, E. faecalis JH2-2(pIL-E), was
immune to C. beijerinckii ATCC 25752 culture supernatant, as
determined in a plate assay, and did not produce bacteriocin
FIG. 3. Alignment of the putative ATP binding proteins involved in circularin A (CirD, CirH) and enterocin AS-48 (AS-48D, BacH) production
with LolD, a protein involved in lipoprotein secretion. Identical residues are indicated by an asterisk. Colons and periods indicate conserved and
semiconserved amino acid substitutions, respectively, according to the ClustalW grouping of amino acids. Dashes indicate gaps introduced in the
sequence to maximize alignment. Walker A, Walker, and ABC transporter B motifs are indicated.
TABLE 2. Characteristics of predicted proteins specified by the C. beijerinckii ATCC 25752 cir gene cluster
Protein Genesizea (bp)
Protein
Size (kDa) pl TMb Homologyc Putative function
CfgR 774 30.4 6 0 Response regulators
CfgK 1,275 49.8 6.8 7 Histidine kinases
Cfg01 597 23.2 9.8 5 AgrB regulatory protein
Cfg02 390 14.4 10.17 4 Unknown
CirA 216 7.2 10.9d 2 Enterocin AS-48 CirA precursor
CirB 1,743 68.8 9.4 11 AS-48B (19%) Secretion/immunity
CirC 555 20.9 10.1 4 AS-48C (21%) Maturation
CirD 663 25.7 6.4 0 ATP-binding proteins; AS-48D (31.6%) Secretion/immunity
CirE 147 5.7 10.6 2 AS-48D1 (30%) Immunity
CirG 1,425 51.7 4.6 1 HlyD family of proteins/EmrA/BacG (17%)
CirH 744 27.6 6.1 0 ATP-binding proteins/BacH (40%)
CirI 1,266 45.7 9.7 4 Duf214 domain/permease of ABC transporter/Bacl (32%)
a When multiple putative starts were possible, the longest product was used.
b TM, number of putative transmembrane sequences.
c Homologues were identified by using Blast searches against the NCBI nonredundant protein database or by direct comparison to the proteins involved in enterocin
AS-48 production. The identity of the protein to its homologue involved in enterocin AS-48 production is shown in parentheses.
d The pl of CirA is based on the linear unprocessed protein.
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(Fig. 1), as determined by serial dilution and overlay assays. In
E. faecalis JH2-2(pIL-E), we were able to introduce the cirE
deletion plasmid pCirE (CirA). E. faecalis JH2-2(pIL-E,
pCirE) was immune to C. beijerinckii ATCC 25752 culture
supernatant and produced bacteriocin (Fig. 1). Attempts to
introduce pCirE in E. faecalis JH2-2 alone were unsuccessful,
indicating that cirE is required for proper bacteriocin immu-
nity.
The levels of resistance conferred by pMG-E and pIL-E in
E. faecalis JH2-2, which is able to grow in medium containing
filter-sterilized C. beijerinckii ATCC 25752 culture supernatant
(at the most 3 to 6%, vol/vol), were only two- to fourfold
increased compared to the control strain carrying only
pMG36e, able to grow in medium containing at the most 1.5%
(vol/vol) filter-sterilized C. beijerinckii ATCC 25752 culture
supernatant. This level is lower than the resistance level of E.
faecalis JH2-2(pCirB) or E. faecalis JH2-2(pCirD), both
also expressing only cirE as a functional immunity system.
Complementing pIL-E with pCirDE in E. faecalis JH2-2 did
not restore the resistance level to that of E. faecalis JH2-
2(pCirD), indicating that the lower resistance level is not due
to the absence of auxiliary factors not present on pMG-E or
FIG. 4. Alignment of CirI with BacG (56), FtsX (6), and LolC and LolE (37). The consensus motif G-X9-F-X10-G for ortholog group 3-1 type
ABC transporters is indicated. Predicted transmembrane domains are indicated in bold. The region constituting the predicted DUF214 domain
is indicated by a line above the sequences. Identical residues are indicated by an asterisk, whereas colons and periods indicate conserved and
semiconserved amino acid substitutions, respectively, according to the ClustalW grouping of amino acids. Gaps were introduced in the sequence
to maximize alignment.
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pIL-E. Taken together, these results confirm that CirE is the
dedicated circularin A immunity protein and that expression of
cirE alone is sufficient for immunity.
DISCUSSION
The region surrounding the structural gene cirA of the cir-
cular bacteriocin circularin A of C. beijerinckii ATCC 25752
encompasses 11 genes. Upstream of cirA there are four genes,
of which two could encode a two-component regulatory sys-
tem. Together with the presence of an AgrB homologue
(Cfg01), this presents the possibility of regulation of bacterio-
cin expression. Two-component systems are often involved in
the regulation of bacteriocin expression, and their genes are
normally located near the bacteriocin operon (27). The homol-
ogy to the Agr system of Staphylococcus aureus, which consists
of a two-component system, a processing protein (AgrB) and a
signaling peptide (AgrD), involved in regulation of virulence
factors (40, 61) suggests a similar regulatory mechanism, al-
though we could not identify an ArgD homologue in our se-
quence and have not further addressed the possible involve-
ment of CfgR and CfgK in CirA expression.
We show here that the region cirABCDEGHI is involved in
bacteriocin production and secretion. The genes cirABCDE
represent the minimal region required for bacteriocin process-
ing and secretion in the heterologous host E. faecalis JH2-2, as
deletion of only a single gene from this cluster causes loss of
either bacteriocin production or cell viability. The genetic or-
ganization of the region cirABCDEGHI seems rather com-
pressed, as several genes overlap. This set-up suggests that
translational coupling, a gene-regulatory mechanism often
used in operons in which the stoichiometry of gene expression
is important (36), may occur.
The minimal requirements for extracellular circularin A ac-
tivity are production, processing, circularization, and secretion
of the bacteriocin, while the producer cell should be immune to
the bacteriocin. All these features should in principle be en-
coded by cirABCDE. Here, we show that resistance to circula-
rin A is acquired via at least two independent systems. First,
expression of cirE confers a certain level of immunity to the
expressing strain, which is essential for the bacteria to be able
to produce and withstand CirA. CirE has a very high and
contains two possible transmembrane helices, which make
membrane localization of the protein very likely. Its small size,
high isoelectric point, and two predicted transmembrane heli-
ces are characteristics that CirE has in common with AS-48D1,
the immunity protein of the circular bacteriocin enterocin AS-
48, and with the proteins PepI, EciI, LasJ, and DviA, which
have all been shown or postulated to be involved in immunity
to the unrelated bacteriocins Pep5, epicidin 280, lactocin S,
and divergicin A, respectively (18, 41, 44, 50, 59). The immu-
nity mechanism of these proteins is unknown, but PepI has
been suggested to inhibit pore formation by Pep5 (46).
The second system conferring reduced sensitivity to CirA
depends on the combined activity of CirB and CirD. Together,
these proteins form a putative ABC transporter in which CirB
is the transporter and CirD provides the nucleotide-binding
domain. The putative transporter CirBD confers a basal level
of CirA resistance, which is, however, insufficient to support
bacteriocin production by the heterologous host that we used;
a viable clone of E. faecalis JH2-2(pCirE) could not be ob-
tained. CirBD (most likely) also function in CirA secretion, as
ABC transporters are often implicated in bacteriocin secretion
(10). The fact that proteins required for secretion of a bacte-
riocin can be involved in resistance has been shown for McbE
and McbF, which are involved in microcin B17 production
(13). The secretion proteins of the lantibiotic nisin were sug-
gested to fulfill a similar role, but involvement of NisI and/or
NisFEG, via a regulatory loop inducing expression of the re-
spective genes, cannot be excluded (29, 43). Resistance is most
probably obtained by the pumping out of the bacteriocin (42,
43, 46). In conclusion, CirBD confer low-level resistance by
virtue of their ability to secrete CirA, while CirE shows struc-
tural homology to other bacteriocin immunity proteins, which
identifies it as the dedicated CirA immunity protein.
Based on homology studies, CirGHI could constitute an-
other transporter. CirG probably has an auxiliary function, as
it is homologous to the HlyD family of proteins, many of which
are accessory proteins in the export of drugs or toxic proteins,
such as hemolysin (52), lactococcin A (53), and colicin V (15).
CirH and CirI probably form an ABC transporter of the Lol-
CDE type (60): CirH is homologous to LolD, while CirI is
homologous to both LolC and LolE. The CirGHI homologues
in the enterocin AS-48 system (BacGHI/AS-48FGH) enhance
the expression of enterocin AS-48 (56) and the resistance to
exogenous enterocin AS-48 (8), roles we have not investigated
for CirGHI yet. The homology to the LolCDE system further-
more suggests that active transport, perhaps from the outer
leaflet of the membrane, as shown for LolCDE (60), is in-
volved in this enhancing effect by making more bacteriocin
available. The NisFEG system fulfills such a function in en-
hancement of nisin secretion (43), but this system is not very
homologous to CirGHI or LolCDE.
No experimental evidence has been obtained to identify the
protein(s) involved in the processing and/or circularization of
the CirA prepeptide. As CirBD together form a putative ABC
transporter and cirE confers bacteriocin immunity, the essen-
tial protein CirC is a likely candidate to perform this func-
tion(s), either alone or together with CirB and/or CirD. This
notion seems to be supported by the fact that the only other
FIG. 5. Heterologous production of circularin A by E. faecalis
JH2-2, as visualized in a colony overlayer assay with Lactobacillus sake´
ATCC 15521 as the indicator strain. (A) E. faecalis JH2-2(pMGAE1);
(B) E. faecalis JH2-2(pCir); (C) E. faecalis JH2-2(pMG36c).
5846 KEMPERMAN ET AL. APPL. ENVIRON. MICROBIOL.
CirC homologue is AS-48C, encoded by the enterocin AS-48
gene cluster of E. faecalis.
In conclusion, we have identified five genes essential for
circularin A production and have shown that three of these
genes (cirBDE) are involved in bacteriocin resistance. Future
studies will be performed to determine the mechanism of cir-
cularization and the possible role of CirC therein.
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